Lemon Blend

Lemon Blend is a multi-component, research-grade formulation supplied as a chemically characterized blend for laboratory investigation of enzyme–lipid interactions, membrane biology, cofactor-dependent redox processes, and model systems involving natural lipid- modulating constituents. The formulation combines Bromelain (a proteolytic enzyme complex), Lecithin (phospholipid mixture, primarily phosphatidylcholine), Riboflavin (Vitamin B2) (a flavin cofactor precursor), and natural lipid-modulators selected for compatibility in analytical and preclinical research workflows.

In research settings, Lemon Blend is used as a tool preparation to support enzyme activity assays, lipid emulsification and transport studies, membrane fluidity and phospholipid turnover experiments, cofactor-dependent oxidative metabolism, and formulation stability assessments. The combination enables exploration of multifactor systems where enzymatic activity, lipid handling, and redox chemistry intersect, without reliance on endogenous biological mixtures.

For Research Use Only. Not for Human Consumption.

PeptideName
Lemon Blend (Bromelain•Lecithin•Riboflavin [Vitamin B2]•Natural Lipid-Modulators)

Peptide Class
Multi-component research blend; enzyme + phospholipids + vitamin cofactor + lipid-modulating constituents
(non-peptide formulation)

Amino Acid Sequence
Not applicable
(Bromelain is an enzyme complex; other components are non-peptidic)

Molecular Formula
Not applicable as a single entity
(component-specific formulas are provided individually on the lot-specific COA)

Molecular Weight
Not applicable as a single entity
(Bromelain is a mixture of proteases; Lecithin is a phospholipid mixture; Riboflavin MW≈376.36 g/mol)

PeptideType
Non-peptide, multi-component research formulation

Chemical Structure
Composite formulation comprising a proteolytic enzyme complex (Bromelain), phospholipidassemblies(Lecithin), aflavin cofactor precursor (Riboflavin), and naturally derived lipid-modulating molecules; components are not covalently linked.

Solubility
Apparent solubility varies by component and experimental conditions.
Bromelain: soluble in aqueous buffers
Lecithin: dispersible/emulsifiable in aqueous systems; soluble in organic solvents
Riboflavin: sparingly soluble in water; improved solubility under buffered or light-protected conditions

Stability Characteristics
Dry form: Store protected from light, heat, and moisture at 2–8 °C or as specified on the COA.
Prepared dispersions/solutions: Stability depends on pH, temperature, light exposure, and solvent system; prepare fresh or aliquot and store under controlled conditions. Avoid prolonged light exposure due to riboflavin photosensitivity.

Source Classification
Mixed origin (plant-derived enzyme, phospholipid fraction, synthetic vitamin)

Purity Specification
≥98% (HPLC or enzymatic assay)
Identity confirmed by assays
Batch-specific Certificate of Analysis (COA) available

Localized Fat Reduction & Adipocytolysis Models
Lemon Blend is referenced within injectable adipolysis research frameworks, whereformulations containing lipid-active or bile-acid–like compounds are studied for their ability toinduce adipocyte membrane disruption and lysis. Preclinical and clinical literature on injectablefat-dissolving agents demonstrates that adipocytolysis leads to localized fat-volume reductionand subsequent subcutaneous tissue remodeling, providing a comparative research context forLemon Bottle–type formulations. [1]

Body Contouring & Subcutaneous Tissue Remodeling
Following adipocyte breakdown, research models describe a localized inflammatory cascade,recruitment of macrophages, and activation offibroblasts, resulting in extracellular matrixreorganization and contour changes. Studies on ATX-101 (deoxycholic acid injectable) providea well-characterized reference model demonstrating measurable reductions in submental fatand tissue contour modification, serving as a benchmark for evaluating similar lipid-modulatingformulations. [2,3]

Metabolic Pathways & Lipid Oxidation Research
Certain Lemon Bottle–type formulations include riboflavin (Vitamin B2), which functions as aprecursor to FAD and FMN, essential cofactors in mitochondrial fatty-acidβ-oxidation.Research into riboflavin-dependent enzymes supports its inclusion in metabolic clearance andlipid-handling studies, particularly following the release of free fatty acids during adipocytedisruption. [4]

Inflammation Modulation & Tissue Recovery Studies
Enzymatic components such as bromelain are frequently examined in inflammation and tissue-recovery research. Experimental studies investigate bromelain’s proteolytic activity, cytokinemodulation, and potential effects on extracellular matrix turnover, making it relevant to post-intervention tissue remodeling and recovery models. [5]

1. Walker P et al. (2022). Injectable treatments for localized fat reduction: mechanisms and outcomes. Frontiers in Endocrinology. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.841889/full

2. Rzany B et al. (2014). ATX-101 for reduction of submental fat: mechanism of action and clinical data. British Journal of Dermatology. https://academic.oup.com/bjd/article/170/2/445/6614988

3. Walker PS, Hexsel D. (2014). Injection adipolysis: mechanisms, agents, and future directions. Journal of Clinical and Aesthetic Dermatology. https://jcadonline.com/injection-adipolysis-mechanisms-agents-and-future-directions/

4. Powers HJ. (2003). Riboflavin (vitamin B-2) and health. The American Journal of Clinical Nutrition. https://academic.oup.com/ajcn/article/77/6/1352/4689808

5. Maurer HR. (2001). Bromelain: biochemistry, pharmacology and medical use. Cellular and Molecular Life Sciences. https://link.springer.com/article/10.1007/PL00000936